InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Casdin Private Growth Equity Fund, L.P.. Officer active across 1 companies, notably Verve Therapeutics, Inc.. Cumulatively, 12 filings have been published. Total volume traded: €39.4m. The latest transaction was disclosed on 3 August 2021 — C. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
126,185 shares
Common Stock, par value $.001 per share
SEC:0000919574-21-006570·
126,185 shares
Common Stock, par value $.001 per share
SEC:0000919574-21-006570:0·
02,374,849 shares0
Common Stock
SEC:0001209191-21-049765:0·
02,374,849 shares0
Common Stock
SEC:0001209191-21-049765·
€20m1,800,000 shares@ €10.9308100.0% of flow
Common Stock, par value $0.01 per share
SEC:0000919574-21-004808·
Ideal exit: 26 Apr 2022 (T+270)
€20m1,800,000 shares@ €10.930817.66% mcap50.0% of flow
Common Stock, par value $0.01 per share
SEC:0000919574-21-004808:0·
Ideal exit: 26 Apr 2022 (T+270)
04,209,573 shares0
Common Stock
SEC:0001628280-21-014732:0·
04,209,573 shares0
Common Stock
SEC:0001628280-21-014732·
620,571 shares
Common Stock
SEC:0000899243-21-025300:0·
1,007,311 shares
Common Stock
SEC:0000899243-21-025301:0·
620,571 shares
Common Stock
SEC:0000899243-21-025300·
1,007,311 shares
Common Stock
SEC:0000899243-21-025301·
12 of 12 declarations
